Indications for Use :
Rabeprazole sodium delayed-release tablets is a proton pump inhibitor (PPI) indicated in adults for: Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) , Maintenance of Healing of Erosive or Ulcerative GERD, Treatment of Symptomatic GERD, Healing of Duodenal Ulcers , Helicobacter pylori Eradication to Reduce Risk of Duodenal Ulcer Recurrence, Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome, Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome.In adolescent patients 12 years of age and older for Short-term Treatment of Symptomatic GERD
Inactive Ingrediant :
Mannitol, Crospovidone, Magnesium Oxide, Isopropyl Alcohol, Sodium Stearyl Fumarate, Magnesium Stearate, Ethyl Celluloses, Hypromellose phthalate (31% Phthalate, 170 CST), Alcohol, Carnauba Wax, Diacetylated Monoglycerides, Polyvinyl Alcohol, Talc, Titanium Dioxide, Polyethylene Glycol, Lecithin, Soybean, Ferric Oxide Yellow, Shellac, Ferrosoferric Oxide, Propylene Glycol, Butyl Alcohol, Ammonia, Hydroxy Propyl Cellulose